Artificial intelligence (AI) has been widely used to discover new drugs, but Singapore-based ChemT Biotechnology<\/a> is betting the technology can also help solve one of the pharmaceutical industry\u2019s biggest challenges: manufacturing them at scale.<\/p>\n The startup said it had secured $4 million in its Seed funding round, anchored by Wavemaker Ventures<\/a> and SEEDS<\/a>, to expand its AI-driven platform.<\/p>\n The platform aims to improve biologics manufacturing, a process that ChemT said often hampered by long development timelines, unpredictable yields, and high production costs.<\/p>\n The round brings ChemT\u2019s total funding to $5 million within 18 months, including $1 million in angel investment. Other investors in the seed round include Wavemaker 360 Health, Draper University Ventures, and Temasek Life Sciences Accelerator, per the announcement.<\/p>\n ChemT said it applies AI directly to manufacturing processes, helping pharmaceutical companies better understand and control how cells behave during production.<\/p>\n \u201cOur customers come to us because they are stuck \u2013 development timelines stretch for years, processes break when you try to scale them,\u201d said Dr. Ling Wu, co-founder and President of ChemT Biotechnology.<\/p>\n At the centre of the company\u2019s technology is CelMo, an AI-powered \u201cvirtual cell\u201d platform trained on proprietary biological sequencing data and validated through laboratory experiments.<\/p>\n The platform, according to ChemT, is designed to simulate how cells respond to manufacturing conditions, genetic modifications, and other stresses, enabling manufacturers to identify ways to improve productivity and scalability.<\/p>\n The fresh capital will be used to expand ChemT\u2019s AI and experimental infrastructure, advance its AI-designed molecular products toward regulatory readiness, and grow its commercial partnerships, according to the announcement.<\/p>\n The company also plans to extend its platform beyond CHO and T cells into stem cells, natural killer cells, and HEK cells, which are used in gene therapy and biologics production.<\/p>\n<\/article>\n<\/div>\n Artificial intelligence (AI) has been widely used to discover new drugs, but Singapore-based ChemT Biotechnology is betting the technology can also help solve one of…<\/p>\n","protected":false},"author":1,"featured_media":62719,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[2611],"tags":[],"class_list":["post-62718","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-buzz-headlines","wpcat-2611-id"],"_links":{"self":[{"href":"https:\/\/sgbuzz.com\/index.php?rest_route=\/wp\/v2\/posts\/62718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sgbuzz.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sgbuzz.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sgbuzz.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sgbuzz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=62718"}],"version-history":[{"count":0,"href":"https:\/\/sgbuzz.com\/index.php?rest_route=\/wp\/v2\/posts\/62718\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sgbuzz.com\/index.php?rest_route=\/wp\/v2\/media\/62719"}],"wp:attachment":[{"href":"https:\/\/sgbuzz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=62718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sgbuzz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=62718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sgbuzz.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=62718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n
\n
Read Full Article At Source <\/a>
\n